The Centers for Medicare & Medicaid Services (CMS) recently announced its intent to engage in rulemaking to update the Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs (commonly referred to as the Meaningful Use Program) beginning in 2015. CMS expects to publish a new rule this spring to respond to provider concerns about software implementation, information exchange readiness, and the 2015 reporting requirements. CMS is considering proposals to:
- Realign hospital EHR reporting periods to the calendar year to allow eligible hospitals more time to incorporate 2014 Edition software to their workflows, and to better align with other CMS quality programs;
- Modify aspects of the Meaningful Use Program to match long-term goals of the program, reduce complexity, and lessen providers’ reporting burdens; and
- Shorten the EHR reporting period in 2015 to 90 days to accommodate these changes. The new rule should allow providers additional time to continue their EHR transitions.
The new rule would reflect recent developments in the industry, and progress toward program goals achieved since the Meaningful Use Program began in 2011. For the past several years, CMS has incentivized hospitals and eligible providers to adopt and make “meaningful use” of EHR technology through the Meaningful Use Program. Over $17.2 billion in Medicare incentive payments and $8.7 billion in Medicaid incentive payments have been made to hospitals and eligible professionals through these programs.
This new rule is distinct from the forthcoming Stage 3 proposed rule, which is expected to be released in March of this year. CMS intends to limit the scope of the Stage 3 proposed rule to the requirements and criteria for meaningful use in 2017 and subsequent years.
This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney.
This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary.
The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites.
In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.